Scholar Rock Holding (SRRK) Cash from Investing Activities Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -27.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.22% |
| Dec 31, 2025 | 696.90% |
| Sep 30, 2025 | 34.07% |
| Jun 30, 2025 | 24.28% |
| Mar 31, 2025 | 35.53% |
| Dec 31, 2024 | -105.13% |
| Sep 30, 2024 | 120.73% |
| Jun 30, 2024 | -13.79% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 41.05% |
| Sep 30, 2023 | 38.19% |
| Jun 30, 2023 | -33.73% |
| Mar 31, 2023 | 17.06% |
| Dec 31, 2022 | -84.63% |
| Sep 30, 2022 | -26.39% |
| Jun 30, 2022 | 28.26% |
| Mar 31, 2022 | -29.66% |
| Dec 31, 2021 | 35.42% |
| Sep 30, 2021 | 95.66% |
| Jun 30, 2021 | 46.96% |
| Mar 31, 2021 | 43.52% |
| Dec 31, 2020 | -183.53% |
| Sep 30, 2020 | -81.68% |